SYNDAX PHARMACEUTICALS INC (SNDX) Stock Balance Sheet
NASDAQ:SNDX - Nasdaq - US87164F1057 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 133.02M | 295.39M | 74.40M | 222.00M | 115.20M | |||
| Marketable Securities | 273.38M | 282.19M | 410.00M | 224.90M | 182.50M | |||
| Receivables | 4.69M | 1.23M | 4.10M | 400.00K | 200.00K | |||
| Other Current Assets | 3.72M | 2.07M | 1.30M | 1.10M | 900.00K | |||
| Total Current Assets | 414.81M | 580.88M | 489.80M | 448.40M | 298.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 756.00K | 1.50M | 1.10M | 1.30M | 500.00K | |||
| Investments And Advances | 10.03M | 29.83M | 5.50M | N/A | N/A | |||
| Other Non-Current Assets | 217.00K | 680.00K | 900.00K | 0.00 | 1.30M | |||
| Total Non-Current Assets | 11.00M | 32.00M | 7.40M | 1.30M | 1.70M | |||
| TOTAL ASSETS | 425.81M | 612.88M | 497.20M | 449.70M | 300.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 10.00K | 12.00K | 0.00 | 0.00 | 2.30M | |||
| Accrued Expenses | 48.96M | 40.89M | 24.70M | 14.80M | 11.60M | |||
| Accounts Payable | 4.90M | 9.96M | 4.40M | 5.70M | 3.50M | |||
| Other Current Liabilities | 5.51M | 7.23M | 0.00 | 200.00K | 1.50M | |||
| Total Current Liabilities | 59.38M | 58.10M | 29.10M | 20.70M | 18.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.00K | 10.00K | 0.00 | 19.90M | 17.80M | |||
| Other Non-Current Liabilities | 0.00 | 578.00K | 700.00K | 700.00K | 11.70M | |||
| Total Non-Current Liabilities | 2.00K | 588.00K | 700.00K | 20.60M | 29.50M | |||
| TOTAL LIABILITIES | 59.38M | 58.68M | 29.80M | 41.30M | 48.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.13B | -902.40M | -693.00M | -543.70M | -568.60M | |||
| Additional Paid In Capital | 1.49B | 1.46B | 1.16B | 952.00M | 820.80M | |||
| Common Shares | 9.00K | 8.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 371.00K | 218.00K | -800.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 85.57M | 84.83M | 68.10M | 55.00M | 47.90M | |||
| Tangible Book Value per Share | 4.28 | 6.53 | 6.86 | 7.43 | 5.27 | |||
| Total Shareholders' Equity | 366.43M | 554.20M | 467.40M | 408.40M | 252.20M | |||
| TOTAL LIABILITIES AND EQUITY | 425.81M | 612.88M | 497.20M | 449.70M | 300.60M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | N/A | 0.05 | 0.07 | |||
| Current Ratio | 6.99 | 10.00 | 16.83 | 21.66 | 15.81 | |||
| Return On Assets (ROA) | -69.76% | -34.16% | -30.03% | 5.54% | -25.65% | |||
| Return On Equity (ROE) | -81.07% | -37.78% | -31.94% | 6.10% | -30.57% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 4.82% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21